Management of melanoma during pregnancy

Sancy A Leachman; Ryan Jackson; Mark J Eliason; April A Larson; Jean L Bolognia

Management of melanoma during pregnancy

Dermatol Nurs. 2007 Apr;19(2):145-52, 161.

Authors

Sancy A Leachman¹, Ryan Jackson, Mark J Eliason, April A Larson, Jean L Bolognia

Affiliation

¹ University of Utah Health Sciences Center, Department of Dermatology, and Huntsman Cancer Institute Melanoma Program, University of Utah, Salt Lake City, UT, USA.

PMID: 17526302

Abstract

There is no conclusive evidence that pregnancy adversely affects overall survival in patients with melanoma. Clinicians caring for pregnant patients should be as suspicious of changes in melanocytic nevi in these patients as they are for nonpregnant patients. Treatment of early-stage melanoma is the same irrespective of whether or not the patient is pregnant. Chemotherapeutic regimens for metastatic disease administered during pregnancy have not demonstrated significant efficacy.

Publication types

Review

MeSH terms

Adult
Age Distribution
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Causality
Female
Humans
Incidence
Maternal Age
Melanoma* / diagnosis
Melanoma* / epidemiology
Melanoma* / therapy
Middle Aged
Neoplasm Staging / methods
Postnatal Care
Pregnancy
Pregnancy Complications, Neoplastic* / diagnosis
Pregnancy Complications, Neoplastic* / epidemiology
Pregnancy Complications, Neoplastic* / therapy
Pregnancy Outcome
Prenatal Care
Prognosis
Prospective Studies
Retrospective Studies
Skin Neoplasms* / diagnosis
Skin Neoplasms* / epidemiology
Skin Neoplasms* / therapy
Survival Rate
United States / epidemiology